9999999997-12-000107.txt : 20120105 9999999997-12-000107.hdr.sgml : 20120105 20120105135330 ACCESSION NUMBER: 9999999997-12-000107 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20120105 DATE AS OF CHANGE: 20120105 20120105 20120105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ANTARES PHARMA, INC. CENTRAL INDEX KEY: 0001016169 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411350192 STATE OF INCORPORATION: DE FISCAL YEAR END: 1208 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-32302 FILM NUMBER: 12510382 BUSINESS ADDRESS: STREET 1: 250 PHILLIPS BLVD STREET 2: SUITE 290 CITY: EWING STATE: NJ ZIP: 08618 BUSINESS PHONE: 609-359-3020 MAIL ADDRESS: STREET 1: 250 PHILLIPS BLVD STREET 2: SUITE 290 CITY: EWING STATE: NJ ZIP: 08618 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20060120 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20020520 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/ DATE OF NAME CHANGE: 20010604 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C0S(#`@;V)J#3P\+TQI;F5AF4@-38O5'EP92]84F5F+U=;,2`R(#%=/CYS=')E86T-"FC>8F)D$&!@ M8F#R`A(,4X`$XPT@P9(`)-C5@<0G(,'(L`LDR\"(3OQGG/D'(,``M`X&Y`T* M96YD8F!@8&%@8(IF``*>1@94P,@` MDN5H0!9C@6(&AAL,W`Q0A-%,>LF+#8Q!11@6```,`!.$%JPT* M96YD7!E+U!A9V4^/@UE;F1O8FH--#8@,"!O8FH-/#PO1FEL=&5R+T9L871E M1&5C;V1E+T9IV;2C&Q,"B$HP1U99\6NVCZ^652[LF/7Y4_VM=D5]5NR M71>[DI,%#*3_,O^\(-.\;\M^N>'73;LKMJ2Z&8K10O"KOMA6R\MZO2V9X/.^ MW'UCF>"+Q_N27+'8MKKOFY9_=SUHG5U<0(?8,;H'SAQ\]5K)H'THJ*=0%F5?]IKNU-F/_ M$M((II2"LX3Q@.M"9/"-MB0;;`BRI3KXXRKM/N8YH"_Y0PX/#;.8RX19*6&P M+('D)&'&I"0CJ(8L#[;,R0COA[$HH]W;I=9@I$0XY7B8%XM7BD9M@*91EM?W!E404VQ=;3,`9>1R6C3D-N]'7^ M!GRU42$WZ1-W+&8/'5W1&-@HC04T&L,WZW$JGHX_/9T?#S1V&/%;L`?IP49 M;8%.\=O[N7<4YZ%&XJ0Q[YHL"849QVK$NVZ-]2'&R9F3O3W$.&+SMC'OJAP> MK12T&BF.\FZX@9.\.W`I$B^V-"+>$#4FWD%X*?/*B'FU)?;TD^!U3S&OT>*0 M>=6?S&NB2QHCW*#_*WM0(Q%"T)$9QV+]B(SA__"GQA9]_IIZ3^7QU.LF)6`? M`]3[6X`!`!_B>R4-"F5N9'-TD6B8@/287"LI/9@6VYC+^N_W[U(U*OM M#=T"A)#HXY'WW',/3Z_3P<5[\?+EQ;O)]53XXM6KU].)&%Q,;GVQ>(()\;38 M#B[2U!=*I(\#I6$.GK5(?!'[B=0BW0PTE05RT?"4U+% M(LV.+-+E(I\L0Y%.CU@::RE]WXAT(;SBZ5EX1B9)Z2`;W#D?W-"9P?^UJYWT M<@I/XM;UE)..X3&]O'5_2]_`EN#$Q_6Q3$;X=.R40;DW;:EI'3_`WBJ0<53? M'':*G$O7"YW)AYMKUS-.BB_T1--D(,:SJ:#77UWE.Y,?72]PQK,?W&*MF/R, M,^]<;P2#YN6TD@9Z)8M9*YC^$,(RA%B:QFG?S+?HY8##_(L;.%]%.!3:5YK\ M]GN+2F]&!JKRQL;]2^*3&&KIA_53460W4T+B1B`H-V-(H._,*BP)*T&SC-7L MRDWX)UY8LQW_1)C2Q`W\J$)G3"\(;6G/?86G6B%V:QSPS&(& MH>12<,7Y/E61PC&4?JE,'K[[TICBW6CC:[*D7[0N%[B7'W7 M9GI%=!TERAPO8F6J[$%$-2%Q?C_U=\)C4+LVBEL'LQ! M&7.`L168(%L\2Q?@`C)".0]/Q.[W*+*6*`J(XBDP&>(,4^D:J,^,D2WP1C)H MX'['##S[M;5"0N+N^-(0 M+2P\8Q"-&MEQE[\("1OZEG8M8\L?,2H,6>PP0)ZG4#_A2##!6J6=PI;W+#7, MJXG8`F0K)U'0SB-<]*O,Q2TCFMBOYO"T%OLO\,L#Y1K>]QO[.YU2X#KT@59B M57HJ9S;S=NE`@5I0&DFKDBXJ$#"]E*A#QBS`B##,G(@BR'Y)6>0LL/\:H)>N M*GPM:8?[E3N";=!8RR0LF/A4:$729":YSQGM*P0+M^:=F3&C2D]"J56Q^BU[ MBW73VR.G2]6$+!/YMM8VW&'[H@!H+*>OK@9\M:'F0K&51*ND54&=0H\JT1G) M^*STQAU=L!7PVHV)443!\L!'6+DO\&6X:KG,.[ECE=-6G MV/*_D2"5R*2!8$]U^%)'EJ=+5S/[!3VNGH!4O60'DU594>(S#(=BY7I%!8;% M0XN/1>YI(U6C-9]SO(L<0Z%X'ED/FC$9U/[BO%F5A%69":*233KG+2T5N'!/#;4!:1"V6MM0$@;5OY*BZ&K=%V>$JT&P0! ML>C/WG%IIY5KVP'FSV[S`JZVMAI/02`@<,/:1A42VVP)V[(/.6\:'%,'SP38 MMM=8]HR%L5X+K'Q4@'W[KK]S[BF84C?M'=#2UR*;'#X%1 MNLBJ+T:XUY/H[$V6-&ZR\W]\YU*+T&0.$A"::KYUH6^,&HV!DD8U>I@E\?9` M;%Q2U>SL'5E\N:"C4`:-3SU'A72Y!\?;?5U]SFD?E[<@:*3&OC0C/.*Y^D#K M`-O#>'NY7$'_9!L^N@[Q4D/54S2_V=#UB/_%5=CN_ZNN>-CH!KAK_=]E=LB5 MB3*)Z_CKHVR;6W(*X=.7('V]->H]J]4P.*;4SRO-+K]8#LR/W#)A7TAQ` M6A!;WV'\:?@+YH$3GI$!@(XHQ])$)P&-ZRIC.L7PS5'T**8-[!;;V+IPSM M+V!-+B@J`=('@-@H);4X&4A_`>+,\I("H#AC`I`MDI0-9H/4B62'!#D#V1U` M-E]):@5(C,$YOZ"R*#,]HT3!T-+24L$Q)3\I52&XLK@D-;=8P3,O.;^H(+\H ML20U!:@6:@<(\+L7)58JN"?FYB8J&.D9D>AR(@`H+"&LSR'@,&(4.X\00X#D MTJ(R*).1R9B!`2#``$G&."\-"F5N9'-T7!E+T]B:E-T;3X^R4>65%!%22B1^$@U MB03R!44IR'NJ@B?/5%4(]!2(@&Y$I%0B2DHUHJ*:$8GJB*BI3IX8A`*,N5"` MPXRLF%A`+H08"WFLQA%91N(269?$%9;$AQ,R)N(:F;`S\`30>77!,@*>),:. ML2GL;MYX"($$O%!%$O!B49*`%_$1\&*)"6@%Q?N!@X*VKI-,^9N MVH\YP\??$^O\,MWD5_)NVS_F+\T`5W/'_G7(;C>-I\/2MNW[:;6:D;;^>;7CJ6J_1Y^ZQ[?+NH8'O M<_?7TS3/Z2JX@_9'[D_3>7CZ_GP8V^%M..3QSXD][O-#_^(NL;5OW7T>WTBK MU7]X==N7MX5YVYBWE7G;F;>E>=L:V];XG3=F6V/;&MO6V+;&MC6VK;%MC?]I M[:<``P`MF;*E#0IE;F1S=')E86T-96YD;V)J#3(@,"!O8FH-/#PO3&5N9W1H M(#0Q.3`O4W5B='EP92]834PO5'EP92]-971A9&%T83X^G)E4WI.5&-Z:V,Y M9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM M<'1K/2)!9&]B92!835`@0V]R92`T+C(N,2UC,#0S(#4R+C,W,C&UL;G,Z M&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q M+C`O(CX*("`@("`@("`@/'AM<#I-;V1I9GE$871E/C(P,3(M,#$M,#54,3,Z M-3(Z-#`M,#4Z,#`\+WAM<#I-;V1I9GE$871E/@H@("`@("`@("`\>&UP.D-R M96%T941A=&4^,C`Q,BTP,2TP-50Q,SHU,CHS.2TP-3HP,#PO>&UP.D-R96%T M941A=&4^"B`@("`@("`@(#QX;7`Z365T861A=&%$871E/C(P,3(M,#$M,#54 M,3,Z-3(Z-#`M,#4Z,#`\+WAM<#I-971A9&%T841A=&4^"B`@("`@("`@(#QX M;7`Z0W)E871O&UP34TZ&UP34TZ&UL.FQA;F<](G@M9&5F875L="(^(#PO&UL.FQA;F<](G@M9&5F875L="(O/@H@("`@("`@("`@ M("`\+W)D9CI!;'0^"B`@("`@("`@(#PO9&,Z9&5S8W)I<'1I;VX^"B`@("`@ M("`@(#QD8SIC&UL;G,Z<&1F/2)H='1P.B\O;G,N861O M8F4N8V]M+W!D9B\Q+C,O(CX*("`@("`@("`@/'!D9CI02`Y+C`\+W!D9CI0L"^`-"F5N9'-T7!E+T]B:E-T M;3X^Q,ME)C/PT7GSTBR,G5MJC/0(P@S;!IH_5V^X\VTO=PO M,WX(C'?8YL:#S&=:17PJCL:Q'B=#%0^4&GQ:+"Y*PL)XL